Extracellular signal-regulated kinases 1 and 2 participate in interleukin-17 plus tumor necrosis factor-α-induced stabilization of interleukin-6 mRNA in human pancreatic myofibroblasts

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1591, Issue 1-3, 2002, Pages 69-74

  Andoh, Akira ^a   Shimada, Mitsue ^a   Bamba, Shigeki ^a   Okuno, Takafumi ^a   Araki, Yoshio ^a   Fujiyama, Yoshihide ^a   Bamba, Tadao ^a  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

Author keywords

Extracellular signal regulated kinase; Interleukin; Myofibroblast

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ENZYME INHIBITOR; INTERLEUKIN 17; INTERLEUKIN 6; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME ACTIVATION; GENE INDUCTION; HUMAN; HUMAN CELL; MYOFIBROBLAST; PANCREAS CELL; PRIORITY JOURNAL; PROTEIN STABILITY;

CELLS, CULTURED; FIBROBLASTS; HUMANS; INTERLEUKIN-17; INTERLEUKIN-6; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASES; PANCREAS; RNA STABILITY; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0037135690     PISSN: 01674889     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-4889(02)00250-1     Document Type: Article

References (30)

1. Kopf M., Baumann H., Freer G., Freudenberg M., Lamers M., Kishimoto T., Zinkernagel R., Bluethmann H., Kohler G. Impaired immune and acute-phase responses in interleukin-6-deficient mice. Natura. 368:1994;339-342.
2. Papanicolaou D.A., Wilder R.L., Manolagas S.C., Chrousos G.P. The pathophysiologic roles of interleukin-6 in human disease. Ann. Intern. Med. 128:1998;127-137.
3. Kusske A.M., Rongione A.J., Reber H.A. Cytokines and acute pancreatitis. Gastroenterology. 110:1996;639-642.
4. Kingsnorth A. Role of cytokines and their inhibitors in acute pancreatitis. Gut. 40:1997;1-4.
5. Shimada M., Andoh A., Hata K., Tasaki K., Araki Y., Fujiyama Y., Bamba T. IL-6 secreation by human pancreatic periacinar myofibroblasts in response to inflammatory mediators. J. Immunol. 168:2002;861-868.
6. Freshney N.W., Rawlinson L., Guesdon F., Jones E., Cowley S., Hsuan J., Saklatvala J. Interleukin-1 activates a novel protein kinase cascade that results in the phosphorylation of Hsp27. Cell. 78:1994;1039-1049.
7. Cobb M.H., Goldsmith E.J. How MAP kinases are regulated. J. Biol. Chem. 270:1995;14843-14846.
8. Han J., Lee J.D., Bibbs L., Ulevitch R.J. A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. Science. 265:1994;808-811.
9. Derijard B.M., Hibi, Wu I.H., Barret T., Su B., Deng T., Karin M., Davis R.J. JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain. Cell. 76:1994;1025-1037.
10. Lasa M., Mahtani K.R., Finch A., Brewer G., Saklatvala J., Clark A.R. Regulation of cyclooxygenase 2 mRNA stability by the mitogen-activated protein kinase p38 signaling cascade. Mol. Cell. Biol. 20:2000;4265-4274.
11. Lasa M., Brook M., Saklatvala J., Clark A.R. Dexamethasone destabilizes cyclooxygenase 2 mRNA by inhibiting mitogen-activated protein kinase p38. Mol. Cell. Biol. 21:2001;771-780.
12. Winzen R., Kracht M., Ritter B., Wilhelm A., Chen C.A., Shyu A.B., Muller M., Gaestel M., Resch K., Holtmann H. The p38 MAPkinase pathway signals for cytokine-induced mRNA stabilization via MAP kinase-activated protein kinase 2 and a AU-rich region-targeted mechanism. EMBO J. 18:1999;4969-4980.
13. Miyazawa K., Mori A., Miyata H., Akahane M., Ajisawa Y., Okudaira H. Regulation of interleukin-1b-induced interleukin-6 gene expression in human fibroblast-like synoviocytes by p38 mitogen-activated protein kinase. J. Biol. Chem. 38:1998;24832-24838.
14. Dean J.L.E., Brook M., Clark A.R., Saklatvala J. p38 mitogen-activated protein kinase regulates cyclooxygenase-2 mRNA stability and transcription in lipopolysaccharide-treated human monocytes. J. Biol. Chem. 274:1999;264-269.
15. Montero L., Nagamine Y. Regulation by p38 mitogen-activated protein kinase of adenylate- and uridylate-rich element-mediated urokinase-type plasminogen activator (uPA) messenger RNA stability and uPA-dependent in vitro cell invasion. Cancer Res. 59:1999;5286-5293.
16. Brook M., Sully G., Clark A.R., Saklatvala J. Regulation of tumor necrosis factor α mRNA stability by the mitogen-activated protein kinase p38 signaling cascade. FEBS Lett. 483:2000;57-61.
17. Alessi D.R., Cuenda A., Cohen P., Dudley D.T., Salteil A.R. PD098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J. Biol. Chem. 270:1995;27489-27494.
18. Favata M.F., Horiuchi K.Y., Manos E.J., Daulerio A.J., Stradley D.A., Feeser W.S., van Dyk D.E., Pitts W.J., Earl R.A., Hobbs F., Copeland R.A., Magolda R.L., Scherle P.A., Trzaskos J.M. Identification of a novel inhibitor of mitogen-activated protein kinase kinase. J. Biol. Chem. 273:1998;18623-18632.
19. Cuenda A., Rouse J., Doza Y.N., Meier R., Cohen P., Gallagher T.F., Young P.R., Lee J.C. SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1. FEBS Lett. 364:1995;229-233.
20. Ray A., Tatter S.B., May L.T., Sehgal P.B. Activation of the human "β2-interferon/hepatocyte-stimulating factor/interleukin-6" promoter by cytokines, viruses, and second messenger agonists. Proc. Natl. Acad. Sci. U. S. A. 85:1988;6701-6705.
21. Fossiez F., Banchereau J., Murry R., van Kooten C., Garrone P., Lebecque S. Interleukin-17. Int. Rev. Immunol. 16:1998;541-551.
22. Yao Z., Painter S.L., Fanslow W.C., Ulrich D., Macduff B.M., Spriggs M.K., Armitage R.J. Human IL-17: a novel cytokine derived from T cells. J. Immunol. 155:1995;5483-5486.
23. - T cells. J. Interferon Cytokine Res. 16:1996;611-617.
24. Albanesi C., Scarponi C., Cavani A., Federici M., Nasorri F., Girolomoni G. Interleukin-17 is produced by both Th1 and Th2 lymphocytes, and modulates interferon-γ- and interleukin-4-induced activation of human keratinocytes. J. Invest. Dermatol. 15:2000;81-87.
25. + T lymphocytes and its regulation by protein kinase A pathway. Cytokine. 11:1999;257-266.
26. Yao Z., Fanslow W.C., Seldin M.F., Rousseau A.M., Painter S.L., Comeau M.R., Cohen J.I., Spriggs M.K. Herpesvirus saimiri encodes a new cytokine, IL-17, which binds to a novel cytokine receptor. Immunity. 3:1995;811-821.
27. Westmark C.J., Malter J.S. Extracellular-regulated kinase controls beta-amyloid precursor protein mRNA decay. Brain Res. Mol. Brain Res. 20:2001;193-201.
28. Zhang Z., Sheng H., Shao J., Beauchamp R.D., DuBois R.N. Posttranscriptional regulation of cyclooxygenase-2 in rat intestinal epithelial cells. Neoplasia. 2:2000;523-530.
29. Rutault K., Hazzalin C.A., Mahadevan L.C. Combination of ERK and p38 MAPK inhibitors ablate tumor necrosis factor-α (TNF-α) mRNA induction. J. Biol. Chem. 276:2001;6666-6674.
30. Sirenko O.I., Lofquist A.K., DeMaria C.T., Morris J.S., Brewer G., Haskill J.S. Adhesion-dependent regulation of an A+U-rich element-binding activity associated with AUF1. Mol. Cell. Biol. 17:1997;3898-3906.